spacer
home > epc > spring 2009 > under close examination - the rules of competition
PUBLICATIONS
European Pharmaceutical Contractor

Under Close Examination - The Rules of Competition

In January 2008, the European Commission launched a sector inquiry into EU pharmaceuticals markets under the EC competition rules because information relating to innovative and generic medicines suggested that competition may be restricted or distorted. The motivating force behind the inquiry is the Commissionís perception that there is a decline in innovation in the sector when measured by the number of novel medicines reaching the market, and (not necessarily connected) that there are instances of delayed market entry of generic medicines as compared to what might be expected.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Gerry Kamstra is a Life Sciences lawyer, particularly recognised as a specialist in IP and commercial agreements, and in IP litigation for clients in the life sciences sector. He also leads Bird & Birdís International Life Sciences Group. He obtained a PhD in physiology before qualifying as a lawyer and has advised and represented numerous clients in the life sciences sector, from start-ups to multinationals. Gerry is a member of the Intellectual Property Advisory Committee of the BioIndustry Association.

spacer
Gerry Kamstra
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm accelerates strategy to broaden service offering into commercial manufacturing

MedPharm Ltd, a leading contract provider of topical and transdermal product design and development services, has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
More info >>

White Papers

galenIQ - The smart excipient

BENEO GmbH

galenIQ combines a multitude of outstanding characteristics and is suitable for a wide range of pharmaceutical applications. galenIQ can be used as more than just a bulk excipient. It also serves as an anti-caking agent, anti-humectant agent, stabilizer or oral care and taste agent to mention just a few additional functions.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: itís where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on todayís hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement